Generic drugs market size to increase by USD 176.25 billion; North America to contribute 37% of market growth - Technavio

NEW YORK, Jan. 11, 2023 /PRNewswire/ -- The Generic Drugs Market by Type, Route Of Administration, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market size is forecast to grow by USD 176.25 billion between 2022 and 2027 at a CAGR of 7.11%. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download A PDF Sample Report

Regional Analysis

By region, the global generic drugs market is segmented into North America, Europe, Asia, and Rest of World. North America is estimated to contribute 37% to the growth of the global market over the forecast period. The increasing prevalence of chronic diseases and the presence of prominent generic pharmaceutical companies are driving the growth of the generic drugs market in North America. Buy the report

Company Profiles

The generic drugs market report includes information on the key products and recent developments of leading vendors, including:

• Amgen Inc. - The company offers wide range of generic drugs such as Aimovig, Corlanor, Epogen, and Xgeva.
• Aurobindo Pharma Ltd. - The company offers wide range of generic drugs such as Risperidone and Alendronate Tablets.
• Baxter International Inc. - The company offers wide range of generic drugs such as Azactam and Brevibloc.
• Dr Reddys Laboratories Ltd. - The company offers wide range of generic drugs such as Azacitidina, Bendamustina, and Bortezomib.

Market Dynamics

The market is driven by factors such as rising drug patent expirations, low-cost alternatives, and increased outsourcing of drug discovery and development. However, stringent regulations are hindering market growth.

Competitive Analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample

Market Segmentation

• By type, the market is segmented into small-molecule generics and biosimilars. The small-molecule generics segment accounted for the largest share of the market in 2022.
• By geography, the market is segmented into North America, Europe, Asia, and Rest of World. North America held the largest share of the market in 2022.

Related Reports:

• The antibiotics market is estimated to grow at a CAGR of 6.07% between 2022 and 2027. The size of the market is forecast to increase by USD 17,066.66 million. The rising prevalence of infectious diseases is notably driving the market growth, although factors such as the development of antibiotic-resistant strains may impede the market growth.
• The anti-inflammatory therapeutics market is estimated to grow at a CAGR of 6.7% between 2022 and 2027. The size of the market is forecast to increase by USD 39.32 billion. The unmet need for safer biologics for RA is notably driving the market growth, although factors such as the loss of patents may impede market growth.

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this generic drugs market report?

• CAGR of the market during the forecast period.
• Detailed information on factors that will drive the growth of the market between 2023 and 2027
• Precise estimation of the size of the generic drugs market and its contribution to the parent market.
• Accurate predictions about upcoming trends and changes in consumer behavior.
• Growth of the market across North America, Europe, Asia, and Rest of World.
• A thorough analysis of the market's competitive landscape and detailed information about vendors.
• Comprehensive analysis of factors that will challenge the growth of generic drugs market vendors.

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global generic drugs market 2017 - 2021
• Exhibit 18: Historic Market Size – Data Table on Global generic drugs market 2017 - 2021 ($ billion)

• 4.2 Type Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ billion)

• 4.3 Route of administration Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size – Route of administration Segment 2017 - 2021 ($ billion)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

• 6.1 Market segments 
• Exhibit 30: Chart on Type - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Type - Market share 2022-2027 (%)

• 6.2 Comparison by Type 
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type

• 6.3 Small-molecule generics - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Small-molecule generics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on Small-molecule generics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on Small-molecule generics - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Small-molecule generics - Year-over-year growth 2022-2027 (%)

• 6.4 Biosimilars - Market size and forecast 2022-2027
• Exhibit 38: Chart on Biosimilars - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on Biosimilars - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on Biosimilars - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Biosimilars - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Type 
• Exhibit 42: Market opportunity by Type ($ billion)

7 Market Segmentation by Route of Administration

• 7.1 Market segments 
• Exhibit 43: Chart on Route of Administration - Market share 2022-2027 (%)
• Exhibit 44: Data Table on Route of Administration - Market share 2022-2027 (%)

• 7.2 Comparison by Route of Administration 
• Exhibit 45: Chart on Comparison by Route of Administration
• Exhibit 46: Data Table on Comparison by Route of Administration

• 7.3 Oral - Market size and forecast 2022-2027
• Exhibit 47: Chart on Oral - Market size and forecast 2022-2027 ($ billion)
• Exhibit 48: Data Table on Oral - Market size and forecast 2022-2027 ($ billion)
• Exhibit 49: Chart on Oral - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Oral - Year-over-year growth 2022-2027 (%)

• 7.4 Injectables - Market size and forecast 2022-2027
• Exhibit 51: Chart on Injectables - Market size and forecast 2022-2027 ($ billion)
• Exhibit 52: Data Table on Injectables - Market size and forecast 2022-2027 ($ billion)
• Exhibit 53: Chart on Injectables - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Injectables - Year-over-year growth 2022-2027 (%)

• 7.5 Topical - Market size and forecast 2022-2027
• Exhibit 55: Chart on Topical - Market size and forecast 2022-2027 ($ billion)
• Exhibit 56: Data Table on Topical - Market size and forecast 2022-2027 ($ billion)
• Exhibit 57: Chart on Topical - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Topical - Year-over-year growth 2022-2027 (%)

• 7.6 Inhalers - Market size and forecast 2022-2027
• Exhibit 59: Chart on Inhalers - Market size and forecast 2022-2027 ($ billion)
• Exhibit 60: Data Table on Inhalers - Market size and forecast 2022-2027 ($ billion)
• Exhibit 61: Chart on Inhalers - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Inhalers - Year-over-year growth 2022-2027 (%)

• 7.7 Market opportunity by Route of Administration
• Exhibit 63: Market opportunity by Route of Administration ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 65: Chart on Market share by geography 2022-2027 (%)
• Exhibit 66: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 67: Chart on Geographic comparison
• Exhibit 68: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 China - Market size and forecast 2022-2027
• Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.10 UK - Market size and forecast 2022-2027
• Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.11 India - Market size and forecast 2022-2027
• Exhibit 101: Chart on India - Market size and forecast 2022-2027 ($ billion)
• Exhibit 102: Data Table on India - Market size and forecast 2022-2027 ($ billion)
• Exhibit 103: Chart on India - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on India - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 105: Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 106: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape 
• Exhibit 107: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 108: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 109: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 110: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 111: Matrix on vendor position and classification

• 12.3 Amgen Inc. 
• Exhibit 112: Amgen Inc. - Overview
• Exhibit 113: Amgen Inc. - Product / Service
• Exhibit 114: Amgen Inc. - Key offerings

• 12.4 Aurobindo Pharma Ltd. 
• Exhibit 115: Aurobindo Pharma Ltd. - Overview
• Exhibit 116: Aurobindo Pharma Ltd. - Product / Service
• Exhibit 117: Aurobindo Pharma Ltd. - Key offerings

• 12.5 Baxter International Inc. 
• Exhibit 118: Baxter International Inc. - Overview
• Exhibit 119: Baxter International Inc. - Business segments
• Exhibit 120: Baxter International Inc. - Key news
• Exhibit 121: Baxter International Inc. - Key offerings
• Exhibit 122: Baxter International Inc. - Segment focus

• 12.6 Biocon Ltd. 
• Exhibit 123: Biocon Ltd. - Overview
• Exhibit 124: Biocon Ltd. - Business segments
• Exhibit 125: Biocon Ltd. - Key offerings
• Exhibit 126: Biocon Ltd. - Segment focus

• 12.7 Cadila Pharmaceuticals Ltd. 
• Exhibit 127: Cadila Pharmaceuticals Ltd. - Overview
• Exhibit 128: Cadila Pharmaceuticals Ltd. - Product / Service
• Exhibit 129: Cadila Pharmaceuticals Ltd. - Key offerings

• 12.8 Cipla Ltd. 
• Exhibit 130: Cipla Ltd. - Overview
• Exhibit 131: Cipla Ltd. - Business segments
• Exhibit 132: Cipla Ltd. - Key news
• Exhibit 133: Cipla Ltd. - Key offerings
• Exhibit 134: Cipla Ltd. - Segment focus

• 12.9 Dr Reddys Laboratories Ltd. 
• Exhibit 135: Dr Reddys Laboratories Ltd. - Overview
• Exhibit 136: Dr Reddys Laboratories Ltd. - Business segments
• Exhibit 137: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibit 138: Dr Reddys Laboratories Ltd. - Segment focus

• 12.10 Fresenius SE and Co. KGaA 
• Exhibit 139: Fresenius SE and Co. KGaA - Overview
• Exhibit 140: Fresenius SE and Co. KGaA - Business segments
• Exhibit 141: Fresenius SE and Co. KGaA - Key news
• Exhibit 142: Fresenius SE and Co. KGaA - Key offerings
• Exhibit 143: Fresenius SE and Co. KGaA - Segment focus

• 12.11 Merck and Co. Inc. 
• Exhibit 144: Merck and Co. Inc. - Overview
• Exhibit 145: Merck and Co. Inc. - Business segments
• Exhibit 146: Merck and Co. Inc. - Key news
• Exhibit 147: Merck and Co. Inc. - Key offerings
• Exhibit 148: Merck and Co. Inc. - Segment focus

• 12.12 Novartis AG 
• Exhibit 149: Novartis AG - Overview
• Exhibit 150: Novartis AG - Business segments
• Exhibit 151: Novartis AG - Key offerings
• Exhibit 152: Novartis AG - Segment focus

• 12.13 Pfizer Inc. 
• Exhibit 153: Pfizer Inc. - Overview
• Exhibit 154: Pfizer Inc. - Product / Service
• Exhibit 155: Pfizer Inc. - Key news
• Exhibit 156: Pfizer Inc. - Key offerings

• 12.14 Sanofi SA 
• Exhibit 157: Sanofi SA - Overview
• Exhibit 158: Sanofi SA - Business segments
• Exhibit 159: Sanofi SA - Key news
• Exhibit 160: Sanofi SA - Key offerings
• Exhibit 161: Sanofi SA - Segment focus

• 12.15 Sun Pharmaceutical Industries Ltd. 
• Exhibit 162: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 163: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 164: Sun Pharmaceutical Industries Ltd. - Key offerings

• 12.16 Teva Pharmaceutical Industries Ltd. 
• Exhibit 165: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 166: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 168: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 169: Teva Pharmaceutical Industries Ltd. - Segment focus

• 12.17 Viatris Inc. 
• Exhibit 170: Viatris Inc. - Overview
• Exhibit 171: Viatris Inc. - Business segments
• Exhibit 172: Viatris Inc. - Key offerings
• Exhibit 173: Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 174: Inclusions checklist
• Exhibit 175: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 176: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 177: Research methodology
• Exhibit 178: Validation techniques employed for market sizing
• Exhibit 179: Information sources

• 13.5 List of abbreviations 
• Exhibit 180: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED